Showing 6961-6970 of 20899 results for "".
- Zasocitinib Effective in Moderate to Severe Psoriasis: Analysishttps://reachmd.com/news/study-zasocitinib-effective-moderate-severe-psoriasis/2468601/Results from a recent placebo-controlled trial of zasocitinib showed promise in improving skin clearance for patients with moderate to severe plaque psoriasis. The phase 2b study, conducted across multiple centers in the United States and Canada, included 259 patients treated over 12 week
- Study Links Severe AD with Need for Surgery in Glaucoma Patientshttps://reachmd.com/news/study-links-severe-ad-with-need-for-surgery-in-glaucoma-patients/2468588/Patients suffering from both severe atopic dermatitis (AD) and glaucoma are increasingly likely to need surgical intervention for the glaucoma depending on the severity of their AD, according to a new Journal of Glaucoma study.“Association of Atopic Dermatitis and Ris
- Amlitelimab Reduces AD Symptoms in Phase 2b Trialhttps://reachmd.com/news/amlitelimab-reduces-ad-symptoms-in-phase-2b-trial/2468589/Treatment with amlitelimab, an anti-OX40 ligand antibody, significantly reduced symptoms of atopic dermatitis (AD) and was maintained even after treatment stopped in new research published in the Journal of Allergy and Clinical Immunology.Results from the pha
- A Quarter of Pediatric Deaths at Hospitals Are Preventable, Study Findshttps://reachmd.com/news/a-quarter-of-pediatric-deaths-at-hospitals-are-preventable-study-finds/2468593/Your support helps us to tell the storyFrom reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro
- Roflumilast Cream 0.15% Receives Glamour's Best Eczema Product Award for 2024https://reachmd.com/news/roflumilast-cream-015-receives-glamours-best-eczema-product-award-2024/2468585/Arcutis Biotherapeutics announced today that ZORYVE® (roflumilast) cream 0.15% has been named Best Eczema Product by Glamour magazine in its 2024 Health and Wellness Awards. The cream, which is the first once-daily FDA-approved topical treatment specifically indicated for mild to
- Early Childhood Air Pollution Exposure Linked to Persistent Peanut Allergieshttps://reachmd.com/news/early-childhood-air-pollution-exposure-linked-to-persistent-peanut-allergies/2468576/A recent study from the Murdoch Children's Research Institute (MCRI) and the University of Melbourne has found a significant association between early-life exposure to air pollution and the development and persistence of peanut allergies in children. The study, published in The Journal of All
- Warmer Homes Could Reduce Cardiovascular Risk in Japan, Study Suggestshttps://reachmd.com/news/warmer-homes-could-reduce-cardiovascular-risk-in-japan-study-suggests/2468565/Winter brings increased health risks, particularly for cardiovascular conditions such as hypertension. A recent study from the Institute of Science Tokyo found that well-insulated homes, which help maintain warmer indoor temperatures, may significantly reduce the risk of cardiovascular diseases (
- Small Bursts of Daily Exercise Found to Lower Blood Pressurehttps://reachmd.com/news/small-bursts-of-daily-exercise-found-to-lower-blood-pressure/2468567/New research suggests that even minor increases in daily physical activity, such as climbing stairs or quick bike rides, can meaningfully reduce blood pressure. Just five minutes of additional daily exercise could contribute to improvements, according to a study by University College London (UCL)
- COVID-19 Pandemic Drives Surge in Pediatric Anxiety, Depression, and Suicidalityhttps://reachmd.com/news/covid-19-pandemic-drives-surge-in-pediatric-anxiety-depression-and-suicidality/2468554/The COVID-19 pandemic disrupted nearly every facet of daily life, leaving a lasting impact on children’s and adolescents' mental health worldwide. School closures, social isolation, and constant uncertainty contributed to rising rates of anxiety, depression, and even suicidal behaviors among youn
- Gut Microbiota’s Role in Stress Response Shown to Follow Circadian Patterns, New Study Findshttps://reachmd.com/news/gut-microbiotas-role-in-stress-response-shown-to-follow-circadian-patterns-new-study-finds/2468557/A recent study from University College Cork, led by Professor John Cryan and Dr. Gabriel Tofani of APC Microbiome Ireland, has revealed the critical role of gut microbiota in modulating stress response through interactions with the body’s circadian rhythms. Published in Cell Metabolism,